P

Inventor

SHEN KE-FEI

US14 patents
⚠️ This page may combine multiple inventors who share the name “SHEN KE-FEI”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

EINSTEIN COLL MED

12 patents
US6362194B1Mar 26, 2002

Method and simultaneously enhancing analgesic potency and attenuating dependence liability caused by morphine and other bimodally-acting opioid agonists

EINSTEIN COLL MED115 citations99
US6096756AAug 1, 2000

Method of simultaneously enhancing analgesic potency and attenuating dependence liability caused by morphine and other bimodally-acting opioid agonists

EINSTEIN COLL MED289 citations99
US5767125AJun 16, 1998

Method of simultaneously enhancing analgesic potency and attenuating dependence liability caused by morphine and other bimodally-acting opioid agonists

EINSTEIN COLL MED211 citations99
US5580876ADec 3, 1996

Method of simultaneously enhancing analgesic potency and attenuating dependence liability caused by morphine and other bimodally-acting opioid agonists

EINSTEIN COLL MED186 citations99
US5512578AApr 30, 1996

Method of simultaneously enhancing analgesic potency and attenuating dependence liability caused by exogenous and endogenous opiod agonists

EINSTEIN COLL MED271 citations99
US5472943ADec 5, 1995

Method of simultaneously enhancing analgesic potency and attenuating dependence liability caused by morphine and other opioid agonists

EINSTEIN COLL MED293 citations99
US7026329B2Apr 11, 2006

Method of simultaneously enhancing analgesic potency and attenuating dependence liability caused by morphine and other bimodally-acting opioid agonists

EINSTEIN COLL MED87 citations98
USRE36547EFeb 1, 2000

Method of simultaneously enhancing analgesic potency and attenuating dependence liability caused by exogenous and endogenous opioid agonists

EINSTEIN COLL MED121 citations98
US6395705B2May 28, 2002

Method and composition for treating irritable bowel syndrome using low doses of opioid receptor antagonists

EINSTEIN COLL MED122 citations97
US6194382B1Feb 27, 2001

Method and composition for treating irritable bowel syndrome using low doses of opioid receptor antagonists

EINSTEIN COLL MED159 citations97
US5585348ADec 17, 1996

Use of excitatory opioid receptor antagonists to prevent growth factor-induced hyperalgesia

EINSTEIN COLL MED124 citations97
US6737400B2May 18, 2004

Method and composition for treating irritable bowel syndrome using low doses of opioid receptor antagonists

EINSTEIN COLL MED12 citations72

UNITED BIOMEDICAL INC

1 patent

PAIN THERAPEUTICS INC

1 patent